Search research articles
Contact Us
Filters
Showing results (41-50 of 153) with videos related to
Page
of 16
Sort By:
Biorxiv : the Preprint Server for Biology
|
January 13, 2025
A Differential Ion Mobility Acoustic Ejection Mass Spectrometer System for Screening Isomerization-Mediating Enzyme Drug Targets
Samad Bazargan, Patricia Dranchak, Chang Liu, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
April 11, 2008
A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker
Ming-Hsuang Cho, Andrew Niles, Ruili Huang, et al.
Nature Medicine
|
March 18, 2008
Identification of oxadiazoles as new drug leads for the control of schistosomiasis
Ahmed A Sayed, Anton Simeonov, Craig J Thomas, et al.
Journal of Medicinal Chemistry
|
April 24, 2007
A high-throughput screen for aggregation-based inhibition in a large compound library
Brian Y Feng, Anton Simeonov, Ajit Jadhav, et al.
Assay and Drug Development Technologies
|
January 12, 2010
Comparison of bioluminescent kinase assays using substrate depletion and product formation
Cordelle Tanega, Min Shen, Bryan T Mott, et al.
Plos One
|
March 19, 2013
Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assays
Patricia Dranchak, Ryan MacArthur, Rajarshi Guha, et al.
Nature Chemical Biology
|
July 20, 2007
High-throughput screening assays for the identification of chemical probes
James Inglese, Ronald L Johnson, Anton Simeonov, et al.
Assay and Drug Development Technologies
|
December 15, 2007
Evaluation of micro-parallel liquid chromatography as a method for HTS-coupled actives verification
Anton Simeonov, Adam Yasgar, Carleen Klumpp, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
N4-phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease
Wenwei Huang, Wei Zheng, Daniel J Urban, et al.
Journal of Biomolecular Screening
|
June 2, 2009
Monitoring compound integrity with cytochrome P450 assays and qHTS
Ryan MacArthur, William Leister, Henrike Veith, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 153) with videos related to
Sort By:
Page
of 16
Biorxiv : the Preprint Server for Biology
|
January 13, 2025
A Differential Ion Mobility Acoustic Ejection Mass Spectrometer System for Screening Isomerization-Mediating Enzyme Drug Targets
Samad Bazargan, Patricia Dranchak, Chang Liu, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
April 11, 2008
A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker
Ming-Hsuang Cho, Andrew Niles, Ruili Huang, et al.
Nature Medicine
|
March 18, 2008
Identification of oxadiazoles as new drug leads for the control of schistosomiasis
Ahmed A Sayed, Anton Simeonov, Craig J Thomas, et al.
Journal of Medicinal Chemistry
|
April 24, 2007
A high-throughput screen for aggregation-based inhibition in a large compound library
Brian Y Feng, Anton Simeonov, Ajit Jadhav, et al.
Assay and Drug Development Technologies
|
January 12, 2010
Comparison of bioluminescent kinase assays using substrate depletion and product formation
Cordelle Tanega, Min Shen, Bryan T Mott, et al.
Plos One
|
March 19, 2013
Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assays
Patricia Dranchak, Ryan MacArthur, Rajarshi Guha, et al.
Nature Chemical Biology
|
July 20, 2007
High-throughput screening assays for the identification of chemical probes
James Inglese, Ronald L Johnson, Anton Simeonov, et al.
Assay and Drug Development Technologies
|
December 15, 2007
Evaluation of micro-parallel liquid chromatography as a method for HTS-coupled actives verification
Anton Simeonov, Adam Yasgar, Carleen Klumpp, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
N4-phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease
Wenwei Huang, Wei Zheng, Daniel J Urban, et al.
Journal of Biomolecular Screening
|
June 2, 2009
Monitoring compound integrity with cytochrome P450 assays and qHTS
Ryan MacArthur, William Leister, Henrike Veith, et al.
Page
of 16